BlackRock, Inc.

Position in GRAL — GRAIL, Inc.

CIK 2012383 New York, NY

Position in GRAL

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$244,206,904

+$90,792,970 QoQ

Shares Held

3,577,075

+20.5% QoQ

Ownership

8.01%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 374 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 97% Shared 0% None 3%

Healthcare · as of Jun 30, 2026

BlackRock, Inc. holds $59,796,815,474 across 40 Diagnostics & Research names. GRAL ranks #20 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	30,919,632	$15,501,866,689
2	DHR	Danaher Corp /De/	55,084,630	$10,492,520,314
3	IDXX	Idexx Laboratories Inc /De	8,170,178	$4,301,108,497
4	A	Agilent Technologies, Inc.	25,599,001	$3,400,315,293
5	ILMN	Illumina, Inc.	19,191,398	$3,374,423,500
6	WAT	Waters Corp /De/	8,484,939	$3,182,191,513
7	NTRA	Natera, Inc.	10,914,608	$2,962,770,335
8	IQV	Iqvia Holdings Inc.	14,549,693	$2,811,291,673

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$244,206,904	3,577,075	+20.5%	Shares	Sole	2026-08-07
2026-06-30	$230,485,322	3,376,085	—	Shares	Sole	2026-07-28
2026-03-31	$153,413,934	2,968,536	+0.3%	Shares	Sole	2026-05-13
2025-12-31	$253,196,267	2,958,246	+20.0%	Shares	Sole	2026-02-12
2025-09-30	$145,738,411	2,464,712	+0.7%	Shares	Sole	2025-11-12
2025-06-30	$125,864,069	2,447,765	+84.8%	Shares	Sole	2025-08-12
2025-03-31	$33,820,928	1,324,234	-5.8%	Shares	Sole	2025-05-02
2024-12-31	$25,095,650	1,405,919	+25.2%	Shares	Sole	2025-02-07
2024-09-30	$15,455,760	1,123,239	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.